Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH): a randomized non-inferiority trialVicky M. Coyle, Ronan McMullan, Rosemary A. Barnes et al.|Clinical Microbiology and Infection|2023Cited by 7
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trialCaroline Forde, Vicky M. Coyle, Ronan McMullan et al.|Trials|2020Cited by 6
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCTVicky M. Coyle, Ronan McMullan, Caroline Forde et al.|Health Technology Assessment|2024Cited by 4
The EASI-SWITCH trial: Early switch to oral antibiotic therapy in patients with low risk neutropenic sepsis.Caroline Forde, Victoria Coyle, Ronan McMullan et al.|Journal of Clinical Oncology|2016Cited by 1
1704P Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH trial)Vicky M. Coyle, Ronan McMullan, Caroline Forde et al.|Annals of Oncology|2021Cited by 1